Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245682.RASp3qKwN2zObW-gtkp4RKE9SHf4mnqxmhvw27v9fUO1Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245682.RASp3qKwN2zObW-gtkp4RKE9SHf4mnqxmhvw27v9fUO1Y130_assertion type Assertion NP1245682.RASp3qKwN2zObW-gtkp4RKE9SHf4mnqxmhvw27v9fUO1Y130_head.
- NP1245682.RASp3qKwN2zObW-gtkp4RKE9SHf4mnqxmhvw27v9fUO1Y130_assertion description "[Moreover, our data imply that miR-221 has potential as an miRNA-based therapeutic target for HBV-related HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245682.RASp3qKwN2zObW-gtkp4RKE9SHf4mnqxmhvw27v9fUO1Y130_provenance.
- NP1245682.RASp3qKwN2zObW-gtkp4RKE9SHf4mnqxmhvw27v9fUO1Y130_assertion evidence source_evidence_literature NP1245682.RASp3qKwN2zObW-gtkp4RKE9SHf4mnqxmhvw27v9fUO1Y130_provenance.
- NP1245682.RASp3qKwN2zObW-gtkp4RKE9SHf4mnqxmhvw27v9fUO1Y130_assertion SIO_000772 25483016 NP1245682.RASp3qKwN2zObW-gtkp4RKE9SHf4mnqxmhvw27v9fUO1Y130_provenance.
- NP1245682.RASp3qKwN2zObW-gtkp4RKE9SHf4mnqxmhvw27v9fUO1Y130_assertion wasDerivedFrom befree-2016 NP1245682.RASp3qKwN2zObW-gtkp4RKE9SHf4mnqxmhvw27v9fUO1Y130_provenance.
- NP1245682.RASp3qKwN2zObW-gtkp4RKE9SHf4mnqxmhvw27v9fUO1Y130_assertion wasGeneratedBy ECO_0000203 NP1245682.RASp3qKwN2zObW-gtkp4RKE9SHf4mnqxmhvw27v9fUO1Y130_provenance.